Literature DB >> 1539104

The recognition and management of somatization. What is needed in primary care training.

R J Goldberg1, D H Novack, L Gask.   

Abstract

This article addresses the medical education issues associated with teaching primary care residents about somatization. Specific training designed to recognize and manage somatization involves a hierarchical series of five knowledge domains with associated discrete skills. As a foundation, a biopsychosocial model must be embraced by the medical leadership of the training program. Second, because psychosocial stresses play a critical etiologic role in somatization, the ability to identify relevant psychosocial issues during medical interviewing is a fundamental skill. Third, basic psychiatric diagnostic areas (depression and anxiety) must be mastered as a prerequisite for identifying somatization. Specific interviewing and management techniques are reviewed, along with two current programmatic approaches. Finally, the concept of physician countertransference also must be explicitly addressed as part of the curriculum. Without assuring that these building blocks are in place, residents are likely to become overwhelmed by the management of somatizing patients and continue the pattern of frustration associated with these patients.

Entities:  

Mesh:

Year:  1992        PMID: 1539104     DOI: 10.1016/S0033-3182(92)72021-0

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  2 in total

1.  Psychiatric problems in primary care patients.

Authors:  D H Novack; R J Goldberg
Journal:  J Gen Intern Med       Date:  1996-01       Impact factor: 5.128

2.  Impact of an educational workshop on psychiatrists' attitude towards psychosomatic medicine.

Authors:  Franziska Baessler; Anja Ciprianidis; Fabienne Louise Wagner; Ali Zafar; Thanos Kanellopoulos; Tabea Chiara Baumann; Clara-Louisa Sandmann; Jobst-Hendrik Schultz
Journal:  BMC Psychiatry       Date:  2020-01-06       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.